- The collaboration will deliver products via ISO 13485-certified manufacturing facilities in India
- Partnership will ensure well-equipped labs in remote and rural locations
- “We aim to deliver high-quality, affordable and 100% made in India products”
Cyient, a global engineering and digital technology solutions company, today announced that it has entered into a manufacturing partnership with Agappe to bring to market Count X. The Mispa Count X is designed and developed three-part hematology analyzer by Agappe.
The manufacturing collaboration is claims to make India self-reliant in hematology and enable the setup of well-equipped labs in remote and rural locations across India. Cyient will manufacture certain key components of Mispa Count X at its ISO 13485-certified manufacturing facilities in India.
Made in India Products
Rajendra Velagapudi, Senior Vice President and CEO, Cyient DLM, commented, “We are proud to support the vision of an Atmanirbhar Bharat (self-reliant India) in the healthcare sector. It is a matter of immense pride that with Agappe’s new hematology product, even rural India and other remote locations of the country will have access to the best of diagnostic capabilities.”
Dr. Satheesh Kumar CS, Senior Vice President, Agappe, said, “This partnership will enable Agappe to deliver high-quality, affordable, 100% made-in-India products by taking advantage of Cyient’s ultra-modern manufacturing facilities to manufacture some of the key components of Mispa Count X so as to reduce time-to-market and lower operating costs. We are eager to get started with full-scale production in our manufacturing facility at Cochin and fulfill customer orders on time.”
Cyient’s world-class facilities, project management, sourcing, supply chain management, production processes, buoyed by investments in the latest technologies as well as expertise in the delivery of quality products, make it a preferred manufacturing partner for aerospace, defense, medical, and industrial customers globally.